Please provide your email address to receive an email when new articles are posted on . Abbott announced FDA clearances for two components of the company’s life support system. The CentriMag blood ...
Abbott announced two new clearances from the US Food and Drug Administration (FDA) for the company's industry-leading life support system. With the new indication, the CentriMag Blood Pump for use ...
(RTTNews) - Abbott Laboratories (ABT) announced Tuesday two new clearances from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system. With the new ...
The Impella RP post-approval study data compares to a survival rate of 73% in the Impella RP PMA Study, 42% for surgically implanted CentriMag RVAS HDE study protocol, and 29% - 42% self-reported ...
Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may be just as ...
A Phoenix man is the first in Arizona to survive COVID-19 through a rare form of treatment called extracorporeal membrane oxygenation (ECMO) therapy. Enes Dedic, 53, was on the brink of death with a ...
Abbott's CentriMag™ Blood Pump, previously cleared for use up to six hours, now can be used to provide longer-term life support to critically ill patients, providing doctors more time to make critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback